ctrl K

Citius Oncology Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

0.85

-0.02 (-2.10%)

At close: May 01, 2025, 3:56 PM

0.89

4.23%

After-hours: May 01, 2025, 04:00 PM EDT

Citius Oncology Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-20.57M	-12.12M	-4.86M	n/a
Interest Income	n/a	n/a	n/a	n/a
Pretax Income	-20.57M	-12.12M	-4.86M	-10.11K
Net Income	-21.15M	-12.7M	-5.43M	-10.11K
Selling & General & Admin	15.65M	7.88M	1.43M	n/a
Research & Development	4.93M	4.24M	3.43M	n/a
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	20.57M	12.12M	4.86M	n/a
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	20.57M	12.12M	4.86M	n/a
Income Tax Expense	576K	576K	576K	n/a
Shares Outstanding (Basic)	71.55M	89.48M	90.16M	81.4M
Shares Outstanding (Diluted)	71.55M	89.48M	90.16M	81.4M
EPS (Basic)	-0.3	-1.42	-0.6	-0.00
EPS (Diluted)	-0.3	-1.42	-0.6	-0.00
EBITDA	-20.57M	-12.12M	-4.86M	-10.11K
EBIT	-20.57M	-12.12M	-4.86M	-10.11K
Depreciation & Amortization	n/a	n/a	n/a	n/a